Fred Alger Management’s Revolution Medicines RVMD Stock Holding History

Fred Alger Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.08M	Buy	21,374 +5,124	+32%	+$517K	0.01%	315
2025 Q4	$1.29M	Sell	16,250 -100,530	-86%	-$6.59M	0.01%	343
2025 Q3	$5.45M	Buy	116,780 +135	+0.1%	+$5.29K	0.02%	233
2025 Q2	$4.29M	Sell	116,645 -754	-0.6%	-$29K	0.02%	249
2025 Q1	$4.15M	Sell	117,399 -30,727	-21%	-$1.25M	0.02%	238
2024 Q4	$6.48M	Sell	148,126 -392,547	-73%	-$19.8M	0.03%	216
2024 Q3	$24.5M	Buy	540,673 +518,909	+2,384%	+$22.6M	0.12%	124
2024 Q2	$845K	Buy	+21,764	New	+$813K	﹤0.01%	361
2023 Q4	–	Sell	-4,542	Closed	-$126K	–	488
2023 Q3	$126K	Buy	+4,542	New	+$135K	﹤0.01%	416

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fred Alger Management's RVMD Position: Q1 2026 in Review

Fred Alger Management increased its Revolution Medicines (RVMD) stake by 32% in Q1 2026, buying an estimated $517K and bringing the position to 21,374 shares worth $2.08M. The position accounts for 0.01% of the portfolio, ranked #315.

Fred Alger Management first reported a position in RVMD in Q3 2023 and has held it in 9 quarters since. The position peaked at $24.5M in Q3 2024. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Fred Alger Management held 21,374 shares of Revolution Medicines worth $2.08M as of Q1 2026.
Fred Alger Management bought 5,124 Revolution Medicines shares in Q1 2026, an estimated $517K.
Revolution Medicines made up 0.01% of Fred Alger Management's portfolio in Q1 2026, its #315 holding.
Fred Alger Management first reported a position in Revolution Medicines in Q3 2023 and has held it in 9 quarters since.
Fred Alger Management's Revolution Medicines position peaked at $24.5M in Q3 2024.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.